EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Engineering CAR‐Tregs with Phage‐Selected scFv Enables a New Paradigm for Immune Regulation

Fatih Noyan iD, Matthias Hardtke-Wolenski iD

BioEssays · 2026-07 · 48 (7)

DOI: 10.1002/bies.70164 ↗

At a glance

Übersichtsarbeit in BioEssays, published online on 2026-07-15. Written by Fatih Noyan and 1 co-authors. Institution: Dept. of Gastroenterology, Hepatology, Infectious Disease and Endocrinology, Hannover Medical School, Hannover, Germany. Major MEDLINE topics: Single-Chain Antibodies, T-Lymphocytes, Regulatory, Receptors, Chimeric Antigen. 41 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Regulatory T cells (Tregs) are central to immune tolerance, yet antigen‐specific cell therapies lag behind cytotoxic CAR‐T approaches. Most CAR‐Treg programs still use single‐chain variable fragments (scFvs) derived from monoclonal antibodies optimized for effector function, a bias that may promote CAR clustering, tonic signaling, and lineage instability. Here, we propose a phage‐first binder discovery framework for CAR‐Tregs and state testable hypotheses linking phage‐display selection pressures to scFv biophysical properties and Treg fate. We hypothesize that multi‐parameter selection and counter‐selection can enrich scFvs with moderate affinity, low polyspecificity, and improved framework stability, thereby lowering tonic signaling in defined backbone architectures and preserving FOXP3/TSDR stability under inflammatory stress. We outline a falsifiable two‐phase roadmap—bench triage followed by mechanistic and preclinical validation to determine how scFv properties, expression level, and intracellular signaling domains define an optimal tonic window for durable immune regulation.

Subjects

MeSH terms (MEDLINE)

Single-Chain AntibodiesT-Lymphocytes, RegulatoryReceptors, Chimeric AntigenHumansAnimalsImmune ToleranceImmunotherapy, Adoptive

Author keywords

FOXP3Treg cellcell biologychimeric antigen receptorimmune systemimmune tolerancemonoclonal antibodyscfv antibodies

Substances

Single-Chain AntibodiesReceptors, Chimeric Antigen

Authors and institutions

  • Dept. of Gastroenterology, Hepatology, Infectious Disease and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Inst. of Medical Microbiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

ORCID profiles: Fatih Noyan, Matthias Hardtke-Wolenski

Cite

APA

Noyan, F., & Hardtke-Wolenski, M. (2026). Engineering CAR‐Tregs with Phage‐Selected scFv Enables a New Paradigm for Immune Regulation. BioEssays, 48(7). https://doi.org/10.1002/bies.70164

Vancouver

Noyan F, Hardtke-Wolenski M. Engineering CAR‐Tregs with Phage‐Selected scFv Enables a New Paradigm for Immune Regulation. BioEssays. 2026;48(7). doi:10.1002/bies.70164

BibTeX
@article{Noyan2026,
  author = {Noyan, Fatih and Hardtke-Wolenski, Matthias},
  title = {Engineering CAR‐Tregs with Phage‐Selected scFv Enables a New Paradigm for Immune Regulation},
  journal = {BioEssays},
  year = {2026},
  volume = {48},
  number = {7},
  doi = {10.1002/bies.70164}
}
Start for free →